Hans van Houte, CFO: Nurix Therapeutics NRIX Sell · Filed 04/30

Trade details

Type: Insider sale
Amount: $39,760.2
Shares · price: 2,388 sh · $16.65 a share
Held after: 51,647 sh
Stock: Nurix Therapeutics NRIX
Person: Hans van HouteCFO
Trade date: 26/04/30
Filed: 26/04/30
Days to filing: 0 days

Sold 4.4% of holdings

Share of holding sold: 4.4%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 03/31~05/30

Hans van Houte's recent trades

Hans van HouteCFO
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$110.6K
4,761 sh
$110.6K
Filed 08/04
Traded 08/04
Hans van HouteCFO
Sell10b5-1 planNurix Therapeutics
Sell10b5-1 plan
Nurix Therapeutics
NRIX
$223.4K
13,473 sh
$223.4K
Filed 05/05
Traded 05/05
Hans van HouteCFO
Sell10b5-1 planNurix Therapeutics
Sell10b5-1 plan
Nurix Therapeutics
NRIX
$9,999
582 sh
$9,999
Filed 05/05
Traded 05/05
Hans van HouteCFO
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$238K
14,055 sh
$238K
Filed 05/05
Traded 05/05
Hans van HouteCFO
SellNurix Therapeutics
Sell
Nurix Therapeutics
NRIX
$59.5K
3,588 sh
$59.5K
Filed 01/30
Traded 01/30